Assuit University NICU of Children Hospital
Asyut, Egypt
NCT Number: NCT03310840
Abstract
Background: Neonatal ventilator associated pneumonia (VAP) is a major hospital-acquired infection in acute care settings, associated with high mortality and poor outcome. VAP is considered a preventable infection if the risk factors are managed effectively. The purpose of this study is to evaluate prevalence of ventilator associated pneumonia, its causative organisms, its risk factors and outcome at our NICU.
This study used CDC guidelines for infant's ≤1 year old to diagnose neonatal VAP, in period from April 2018 to March 2019.
Looking for future studies?
Notify Me3 day–2 month
All sexes
Observational
Asyut, Egypt
Background:
Neonatal deaths represent third of the global burden of child mortality [1]. In Egypt, Infections such as pneumonia, meningitis, sepsis/septicemia and other infections account for 28% of deaths during the neonatal period, Survival cannot be achieved without substantial reductions in infection-specific neonatal mortality [2]. Neonatal sepsis is usually classified as early or late onset sepsis. Early sepsis occurs within the first 72 hours of birth and late neonatal sepsis occurs after 72 hours of birth. Early neonatal sepsis is associated with acquisition of microorganism from mother Late neonatal sepsis usually occurs due to the lack of aseptic working conditions [3]. The occurrence of late sepsis is considered an important indicator of quality of care. Mechanical ventilation is an essential, life-saving therapy for patients with critical illness and respiratory failure. These patients are at high risk for complications and poor outcomes, including death, Ventilator-associated pneumonia (VAP), Sepsis, pulmonary embolism, barotrauma, and pulmonary edema. Such complications can lead to longer duration of mechanical ventilation, longer stays in the intensive care unit (ICU) and hospital, increased healthcare costs, and increased risk of disability and death [4, 5]. Ventilator associated pneumonia (VAP) is defined as a nosocomial lower airway infection, i.e. pneumonia, in intubated patients with onset after 48 h or more of invasive mechanical ventilation [6]. VAP is usually caused by airway colonization by potential pathogens; Sources of airway colonization can be the patient's own flora, i.e., bacterial overgrowth in oral secretions, reflux and aspiration of gastric fluid or the patient's environment with its caretakers and equipment [7, 8].
Mechanically ventilated babies face a particular risk because artificial airways bypass the body's defenses against inhaled pathogens and offer new routes for non-air borne pathogens. Intubation associated lesions of pharynx and trachea lead to bacterial colonization by the deterioration of the swallowing reflex and the ciliary functions [9].VAP is one of the most frequently diagnosed nosocomial infections [10] and, after suspected early onset sepsis, second most reason for antibiotic intervention in Neonatal Intensive Care Unit (NICU) [11, 12].VAP incidence can be reduced by infection control measures such as VAP-prevention-bundles [13]. Regarding diagnosis of VAP episode requires a combination of radiological, clinical, and laboratory criteria. However Center for Disease Control and Prevention/ National Nosocomial Infection Surveillance (CDC/NNIS) criteria refers to infants younger than 1 year and do not define specific criteria for the newborn period in term or preterm infants. In spite of this lack of specificity, most studies of VAP performed in NICUs are based on these criteria [14].
Keywords: Newborn, Mechanical ventilation, ventilator-associated pneumonia, risk factors, causative organisms.
'Method's: Design: A prospective, observational cohort surveillance, was carried out at our Neonatal Intensive Care Unit (NICU) was done during a period from April 2018 to March 2019 to neonates who needed mechanical ventilation, reviewing data of diagnosis of neonates with ventilation associated pneumonia used .
Setting: Our NICU is a level III, part of a university-teaching hospital, receives referrals from the whole Upper Egypt. It has approximately 1450 case per year, approximately ~ 5 patients per day. It has approximately 450 case needs MV per year.
Patients:
Inclusion criteria
All inborn and outborn neonates who were admitted to the our NICU during the April 2018- March 2019 were screened for study enrollment and were considered eligible if ventilated for more than 48 hours.
Exclusion criteria
Neonates ventilated with Evidence of neonatal sepsis before ventilated. Meconium aspiration syndromes were excluded. Death within 48 hours of NICU admission.
Intervention:
(Modified CDC guidelines for infants≤1 year old)[5,6,13].
All patient will be subjected to:
Including: Patient data, Perinatal history, Present history, Family history.
i. General physical assessment.
<!-- -->
The clinical criteria for diagnosis; Worsening gas exchange: desaturations pulse oximetry less than 94%, increase ventilation demand,
And at least three of the following Temperature instability Leukopenia (≤4000 WBC/mm3) or leukocytosis (>15,000 WBC/mm3) and left shift Band forms (10%) New onset of purulent sputum or change in character of sputum, or increased respiratory secretions Apnea, tachypnea, nasal flaring with retraction of chest wall or nasal flaring with grunting Wheezing, rales, or rhonchi
We tried to compare the results of BAL versus blood culture in the diagnosis of VAP according to Cantey JB et al[12] ,aimed to intensive role of BAL.
Microorganisms isolated from blood were compared with that isolated from BAL. According to results:
<!-- -->
Ethical considerations:
The aim of the study was explained to each parents of the child before the beginning of the process. A written consent was obtained from those who welcomed to participate in the study. Privacy and confidentiality of all data were assured.
Statistical analysis:
The data were tested for normality using the Kolmogorov-Smirnov test and for homogeneity variances prior to further statistical analysis. Categorical variables were described by number and percent (N, %), where continuous variables described by mean and standard deviation (Mean, SD). Chi-square test used to compare between categorical variables where compare between continuous variables by t-test (One Way ANOVA). A two-tailed p < 0.05 was considered statistically significant. All analyses were performed with the IBM SPSS 20.0 software.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
others
Time frame: from april 2018 to march 2019
to determine incidence and prevalence of neonatal sepsis on mechanically ventilated neonate
Time frame: from april 2018 to march 2018
serial endo tracheal aspirate ever three day to predict neonatal sepsis and type of organisms causing sepsis in ventilated neonate,antibiotic proper usage
Assiut University
Other
A Observational Study on Ventilator-associated Pneumonia as a Risk for Nosocomial Infection in Mechanically Ventilated Neonates In NICU of Assiut University Children Hospital PROTOCOL OF THESIS Descriptive Study
Acronym: nicu eta
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07245277
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Bandung, West Java, Indonesia
View Trial DetailsNCT05856227
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Evanston, Illinois, United States
View Trial DetailsNCT04172012
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases
Babati, Manyara Region, Tanzania
View Trial DetailsNCT05730387
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Vancouver, British Columbia, Canada
View Trial Details